Inventor · disambiguated record
Angela Cacace
Also filed as: CACACE ANGELA · CACACE ANGELA M · CACACE ANGELA MARIE
12 granted patents·30 pending applications·20 citations·filing 2001–2025
87Inventor score
Files withBRISTOL MYERS SQUIBB CO8FULCRUM THERAPEUTICS INC8HOFFMANN LA ROCHE3ARVINAS OPERATIONS INC1BATTAGLINO PETER1
Top patents by PatentIndex Score
42 records- 0195US11359197B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jun 14, 2022·4 cites·18 claims
- 0289US11447775B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Sep 20, 2022·3 cites·20 claims
- 0388US10342786B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jul 9, 2019·4 cites·19 claims
- 0488US2025136988A1Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0587US11912699B2Tau-protein targeting compounds and associatedARVINAS OPERATIONS INC·Filed 2020·Granted Feb 27, 2024·2 cites·21 claims
- 0687US10799523B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Oct 13, 2020·3 cites·8 claims
- 0786US10537560B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2018·Granted Jan 21, 2020·4 cites·28 claims
- 0881US12180478B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Dec 31, 2024·0 cites·20 claims
- 0977US2023257743A1Use of p38 inhibitors to reduce expression of dux4FULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1075US2022282254A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1174US2025327072A1Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1272US2022133704A1P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshdFULCRUM THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1370US11479770B2Use of p38 inhibitors to reduce expression of DUX4FULCRUM THERAPEUTICS INC·Filed 2018·Granted Oct 25, 2022·0 cites·8 claims
- 1470US2022143064A1Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
- 1567US11291659B2P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHDFULCRUM THERAPEUTICS INC·Filed 2020·Granted Apr 5, 2022·0 cites·15 claims
- 1663US12241065B2Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 4, 2025·0 cites·11 claims
- 1762US11077132B2Tau antisense oligomers and uses thereofHOFFMANN LA ROCHE·Filed 2016·Granted Aug 3, 2021·0 cites·13 claims
- 1862US2025188463A1Antisense oligonucleotides targeting alpha-synuclein and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2025·Application pending·0 cites
- 1949US2004214317A1Novel human G-protein coupled receptor, HGPRBMY8, expressed highly in brainBATTAGLINO PETER·Filed 2003·Application pending·0 cites
- 2049US2022017908A1Compositions and methods for increasing fetal hemoglobin and treating sickle cell diseaseFULCRUM THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 2147US2004147732A1Novel human G-protein coupled receptor, HGPRBMY9, expressed highly in brain and testesFiled 2003·Application pending·0 cites
- 2247US2003198976A1Novel human G-protein coupled receptor, HGPRBMY14, related to the orphan GPCR, GPR73Filed 2002·Application pending·0 cites
- 2345US2003186265A1Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cordFiled 2002·Application pending·0 cites
- 2445US2004121330A1Novel human G-protein coupled receptor, HGPRBMY4, and methods of use thereofFiled 2002·Application pending·0 cites
- 2545US2022119811A1Alpha-synuclein antisense oligonucleotides and uses thereofROCHE INNOVATION CT COPENHAGEN AS·Filed 2019·Application pending·0 cites
- 2645US2003175748A1Novel human G-protein coupled receptor, HGPRBMY3, expressed highly in immune- and colon- related tissuesFiled 2002·Application pending·0 cites
- 2745US2003170671A1Novel human G-protein coupled receptor, HGPRBMY6, expressed highly in small intestineFiled 2002·Application pending·0 cites
- 2844US2003100057A1Novel human G-protein coupled receptor, HGPRBMY14, related to the orphan GPCR, GPR73Filed 2002·Application pending·0 cites
- 2944US2003054374A1Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY27Filed 2002·Application pending·0 cites
- 3044US2003064438A1G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereofFiled 2002·Application pending·0 cites
- 3144US2003064381A1Polynucleotide encoding a novel human G-protein coupled receptor, HGPRBMY26, expressed highly in testis and gastrointestinal tissuesFiled 2002·Application pending·0 cites
- 3243US11761951B2Methods of selecting therapeutic moleculesBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 19, 2023·0 cites·19 claims
- 3343US2004121362A1Identification and modulation of a G-protein coupled receptor (GPCR), RAI-3, associated with chronic obstructive pulmonary disease (COPD) and NF-kappaB and E-selectin regulationFiled 2003·Application pending·0 cites
- 3443US2003157598A1Novel human G-protein coupled receptor, HGPRBMY23, expressed highly in kidneyFiled 2001·Application pending·0 cites
- 3541US2003224400A1Novel human G-protein coupled receptor, HGPRBMY11, and variants thereofFiled 2003·Application pending·0 cites
- 3640US2003186360A1Novel human G-protein coupled receptor, HGPRBMY3, expressed highly in immune -and colon-related tissuesFiled 2001·Application pending·0 cites
- 3740US2003022183A1Novel human G-protein coupled receptor, HGPRBMY7, expressed highly in spinal cordFiled 2001·Application pending·0 cites
- 3839US2003054444A1Novel human G-protein coupled receptor, HGPRBMY8, expressed highly in brainFiled 2001·Application pending·0 cites
- 3938US2003096300A1Novel human G-protein coupled receptor, HGPRBMY9, expressed highly in brain and testesFiled 2001·Application pending·0 cites
- 4038US2003044892A1Novel human G-protein coupled receptor, HGPRBMY6, expressed highly in small intestineFiled 2001·Application pending·0 cites
- 4137US2003153063A1Novel human G-protein coupled receptor, HGPRBMY11, expressed highly in heart and variants thereofFiled 2001·Application pending·0 cites
- 4234US2003022237A1Novel human G-protein coupled receptor, HGPRBMY4, expressed highly in prostate, colon, and lungFiled 2001·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →